Psyence Biomedical Ltd.
PBM
$0.5171
-$0.0162-3.04%
NASDAQ
| 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | 09/30/2023 | |
|---|---|---|---|---|---|
| Net Income | -46.59M | -48.87M | -51.15M | -27.65M | -4.17M |
| Total Depreciation and Amortization | 2.00K | 1.10K | 200.00 | 100.00 | -- |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 44.76M | 47.08M | 49.39M | 24.72M | 43.20K |
| Change in Net Operating Assets | -1.04M | -1.11M | -1.17M | 159.50K | 1.49M |
| Cash from Operations | -2.86M | -2.90M | -2.93M | -2.77M | -2.63M |
| Capital Expenditure | -12.20K | -9.00K | -5.80K | -2.90K | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -12.20K | -9.00K | -5.80K | -2.90K | -- |
| Total Debt Issued | 2.78M | 2.64M | 2.50M | 1.60M | 715.00K |
| Total Debt Repaid | -150.00K | -150.00K | -150.00K | -75.00K | -- |
| Issuance of Common Stock | 1.72M | 860.80K | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -145.00K | -72.80K | -600.00 | 1.15M | 2.31M |
| Cash from Financing | 4.21M | 3.28M | 2.35M | 2.68M | 3.02M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | 0.00 | 0.00 | 0.00 | 0.00 | -- |
| Net Change in Cash | 1.34M | 372.50K | -591.60K | -96.20K | 389.80K |